Search for Clinical Trial Results

Sponsored By

Basal Cell Nevus Syndrome - 27 Studies Found

Status Study
Completed Study Name: Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome
Condition: Basal Cell Nevus Syndrome
Date: 2014-06-02
Interventions:
  • Drug: Levulan Levulan applicat
Active, not recruiting Study Name: Study of BMS-833923 in Two Specific Patients With Basal Cell Nevus Syndrome
Condition: Basal Cell Nevus Syndrome
Date: 2014-02-28
Interventions: Drug: BMS-833923 BMS-833923, by mouth, at the dose and schedule administered while enrolled in CA194002.
Completed Study Name: To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS)
Condition:
  • Basal Cell Nevus Syndrome
  • Gorlin Syndrome
    Date: 2009-08-05
    Interventions: Drug: GDC-0449 capsule, 150 mg, one pill daily, 18 months
Completed Study Name: Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas (BCC) in Gorlin Syndrome Patients
Condition: Basal Cell Nevus Syndrome
Date: 2016-04-27
Interventions:
  • Drug: patidegib patidegib gel

Completed Study Name: Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas
Condition:
  • Basal Cell Nevus Syndrome
  • Gorlin's Syndro
    Date: 2012-03-14
    Interventions:
    • Drug: Vismodegib 150 mg per da
Active, not recruiting Study Name: Photodynamic Therapy Using Blue Light or Red Light in Treating Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
Condition:
  • Basal Cell Carcinoma of the Skin
  • Nevoid Basal Cell Carcinoma Syndrome<
    Date: 2014-10-03
    Interventions:
    • Drug: aminolevulinic acid hydrochloride

Terminated Study Name: Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.
Condition:
  • Basal Cell Carcinoma
  • Nevoid Basal Cell Carcinoma Syndrome

    • Date: 2002-11-15
    Interventions: Drug: verteporfin PDT
Completed Study Name: Efficacy, Safety and Pharmacokinetics of Oral LDE225 in Treatment of Patients With Nevoid Basal Cell Carcinoma Syndrome (NBCCS)
Condition:
  • Basal Cell Carcinoma
  • Gorlin Syndrome
  • Drug: LDE225 supplied as 100 m
Completed Study Name: Topical Tazarotene in Treating Patients With Basal Cell Skin Cancer and Basal Cell Nevus Syndrome on the Chest and Back
Condition: Skin Carcinoma
Date: 2008-10-31
Interventions:
  • Drug: tazarotene Applied to th
Completed Study Name: A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients
Condition: Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients
Date: 2009-08-18
Interventions:
  • Drug: Vehicle Placebo cream
Next >>>